Literature DB >> 10077285

Smoking-attributable medical care costs in the USA.

V P Miller1, C Ernst, F Collin.   

Abstract

Medical care costs attributable to cigarette smoking are estimated using an econometric model of annual individual expenditures for four types of medical services: ambulatory, hospital, prescription drug, and other (which includes home health and durable medical equipment and excludes dental and mental health). The model follows the two-part specification of Duan et al. (1983). Estimation is carried out using the 1987 National Medical Expenditure Survey. Fitted values are used to calculate smoking-attributable fractions (SAFs) of expense by type of service and by age and gender category. The overall weighted average SAF is 6.54%. SAFs are generally largest for ambulatory and smallest for hospital expenses. They are larger for males and for the older age categories. The model is analyzed for heteroscedasticity and goodness of fit. Additional analysis using the National Health Interview Survey is conducted to test for the possible effect of not being able to include alcohol consumption in the primary model. A balanced repeated replication analysis is conducted to evaluate the variance of the SAFs. Variances are found to be acceptably small. An extension of the model to support evaluation of smoking-attributable costs for special populations such as individual states, and special insurance pools such as Medicaid recipients, is described. Results for the fifty states are presented. Conclusions and subjects for further research are discussed.

Entities:  

Mesh:

Year:  1999        PMID: 10077285     DOI: 10.1016/s0277-9536(98)00344-x

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  38 in total

Review 1.  Medical costs of smoking in the United States: estimates, their validity, and their implications.

Authors:  K E Warner; T A Hodgson; C E Carroll
Journal:  Tob Control       Date:  1999       Impact factor: 7.552

2.  Psychosocial versus nicotine-only self-report measures for predicting follow-up smoking status.

Authors:  W J McCarthy; Y Zhou; Y I Hser
Journal:  J Behav Med       Date:  2001-02

3.  Evaluating the tobacco settlement damage awards: too much or not enough?

Authors:  Maribeth Coller; Glenn W Harrison; Melayne Morgan McInnes
Journal:  Am J Public Health       Date:  2002-06       Impact factor: 9.308

4.  Economic burden of smoking in Korea.

Authors:  H Y Kang; H J Kim; T K Park; S H Jee; C M Nam; H W Park
Journal:  Tob Control       Date:  2003-03       Impact factor: 7.552

5.  Optimal commodity taxation with moral hazard and unobservable outcomes.

Authors:  Gerard Russo
Journal:  Int J Health Care Finance Econ       Date:  2003-03

6.  Health care costs among smokers, former smokers, and never smokers in an HMO.

Authors:  Paul A Fishman; Zeba M Khan; Ella E Thompson; Susan J Curry
Journal:  Health Serv Res       Date:  2003-04       Impact factor: 3.402

Review 7.  Pharmacoeconomic considerations in the management of smoking cessation.

Authors:  Christine Godfrey; Godfrey Fowler
Journal:  Drugs       Date:  2002       Impact factor: 9.546

8.  Cost of Tobacco-related Cancer Hospitalizations in the U.S., 2014.

Authors:  Eric W Tai; Gery P Guy; C Brooke Steele; S Jane Henley; Michael S Gallaway; Lisa C Richardson
Journal:  Am J Prev Med       Date:  2018-02-01       Impact factor: 5.043

9.  Annual healthcare spending attributable to cigarette smoking: an update.

Authors:  Xin Xu; Ellen E Bishop; Sara M Kennedy; Sean A Simpson; Terry F Pechacek
Journal:  Am J Prev Med       Date:  2014-12-10       Impact factor: 5.043

10.  The economic burden of smoking in California.

Authors:  W Max; D P Rice; H-Y Sung; X Zhang; L Miller
Journal:  Tob Control       Date:  2004-09       Impact factor: 7.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.